CellTran Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 12

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $288K

CellTran General Information

Description

Developer of cell therapy products for treatment of burns and ulcers. The company develops treatment for chronic, complex or non-healing wounds using advanced polymer surface technology and the autologous and allogeneic cells cultured from the patients living cells, providing patients suffering from chronic burns with skin transplants that avoids hostile reactions from the body.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • The Innovation Centre
  • 217 Portobello
  • Sheffield S1 4DP
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • The Innovation Centre
  • 217 Portobello
  • Sheffield S1 4DP
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CellTran Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 28-Oct-2008 $288K Completed Bankruptcy: Admin/Reorg
6. Bankruptcy: Admin/Reorg 16-Jun-2008 Completed Bankruptcy: Admin/Reorg
5. Later Stage VC 24-Aug-2007 Completed Generating Revenue
4. Early Stage VC 04-Aug-2005 Completed Product Development
3. Early Stage VC 01-Feb-2005 Completed Product Development
2. Early Stage VC 01-Jan-2004 $1.05M $1.43M Completed Product Development
1. Seed Round 01-Aug-2000 $377K $377K Completed Startup
To view CellTran’s complete valuation and funding history, request access »

CellTran Patents

CellTran Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-0313569-D0 Method Inactive 12-Jun-2003
AU-2004217726-A1 Cell culture Inactive 05-Mar-2003
CA-2517982-A1 Cell culture Inactive 05-Mar-2003
EP-1601763-A2 Cell culture Inactive 05-Mar-2003
GB-0304918-D0 Cell culture Inactive 05-Mar-2003 A61L27/3886
To view CellTran’s complete patent history, request access »

CellTran Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CellTran Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Finance Yorkshire Growth/Expansion Minority
FusionIP Venture Capital Minority
Innogenetics Corporation Minority
PUK Ventures Fund of Funds Minority
Wellcome Trust Limited Partner Minority
You’re viewing 5 of 7 investors. Get the full list »

CellTran Acquisitions (1)

CellTran’s most recent deal was a Merger/Acquisition with XCELLentis. The deal was made on 02-Oct-2006.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
XCELLentis 02-Oct-2006 Merger/Acquisition Drug Discovery
To view CellTran’s complete acquisitions history, request access »

CellTran FAQs

  • When was CellTran founded?

    CellTran was founded in 2000.

  • Where is CellTran headquartered?

    CellTran is headquartered in Sheffield, United Kingdom.

  • What is the size of CellTran?

    CellTran has 12 total employees.

  • What industry is CellTran in?

    CellTran’s primary industry is Drug Discovery.

  • Is CellTran a private or public company?

    CellTran is a Private company.

  • What is the current valuation of CellTran?

    The current valuation of CellTran is .

  • What is CellTran’s current revenue?

    The current revenue for CellTran is .

  • How much funding has CellTran raised over time?

    CellTran has raised $8.65M.

  • Who are CellTran’s investors?

    Finance Yorkshire, FusionIP, Innogenetics, PUK Ventures, and Wellcome Trust are 5 of 7 investors who have invested in CellTran.

  • When was CellTran acquired?

    CellTran was acquired on 28-Oct-2008.

  • Who acquired CellTran?

    CellTran was acquired by York Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process